ALTTO(c)_2B | R Documentation |
Kaplan-Meier digitized data from ALTTO(c), figure 2B (PMID 26598744). A reported sample size of 8,381 for a primary endpoint of DFS in breast cancer.
`ALTTO(c)_2B`
A data frame of 4,197 observations and 3 variables:
time | event time (in years) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (l, t) | |
Piccart-Gebhart M, Holmes E, Baselga J, et al. Adjuvant Lapatinib and Trastuzumab for Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Results From the Randomized Phase III Adjuvant Lapatinib and/or Trastuzumab Treatment Optimization Trial. J Clin Oncol 2016; 34: 1034–42.
summary(`ALTTO(c)_2B`)
kmplot(`ALTTO(c)_2B`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.